工業大麻概念板塊走強 聯合國正式承認大麻藥用合法性
格隆匯12月4日丨工業大麻概念板塊繼續走強,天津磁卡拉昇封板,通化金馬開盤漲停,龍津藥業漲超8%,雅本化學、美盈森等跟漲。12月2日,聯合國麻醉品委員會(CND)第63屆會議在維也納召開,在推遲近十個月之後,世衞組織關於大麻和大麻相關物質的列管建議再次迎來投票。會議上,憑藉微弱的優勢通過表決,大麻和大麻脂正式從《1961年麻醉品單一公約》附表四中被刪去,這也意味着聯合國層面大麻的醫療用途獲得承認。不過,CND否決了世衞組織的大麻列管調整建議函中的其餘5條建議。業內人士表示,世界衞生組織的六條建議雖然只通過了一條,但也是跨出了巨大的一步,將推動全球大麻醫用產業發展,促進政策升級。六條建議沒有完全通過,也意味着工業大麻產業仍然屬於強監管範疇,監管的護城河和紅利空間仍然在。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.